Pbd Biotech Develops Actiphagea Blood Test That Detectsactivedisease Causing Tuberculosis Infection One Quarter Of The World S Population Is Infected With Latent Tuberculosisltbi Also Known As Inactive Tuberculosisone In Ten People With Ltbi Will Progress To Active Tb Disease It Is Essential To Develop Newer Diagnostic Tests With Significantly Increased Predictive Value For The Development Of Active Disease Among Those Who Are Infected Than The Currently Available Tests For Ltbiwho2017At Pbd Biotechour Mission Is To Support The Scale Up Of Latent Tuberculosis Test And Treat Campaigns With Actiphage To Achieve The Goals Of The Who End Tb Strategyleveraging Actiphage S Unique Role In Detecting Active Tbpbd Aims To Drive Innovation In The Novel Uses For Tb Screening And Drug Management
No conferences found for this company.
| Company Name | Bpd Biotech |
| Country |
India
|
| Address | N/A |
| Telephone | N/A |
| N/A |
